Urokinase-type plasminogen-activator and normal thyroid cell adhesion to the extracellular matrix

Biochimie

Volumn 81, Issue 4, 1999, Pages 355-358

  Ragno, Pia ^a   Montuori, Nunzia ^b   Salzano, Salvatore ^a   Rossi, Guido ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cell adhesion; Plasminogen activation; Thyroid; Urokinase; Urokinase receptor

Indexed keywords

COLLAGEN; FIBRONECTIN; INTEGRIN; INTEGRIN RECEPTOR; LAMININ; PLASMINOGEN ACTIVATOR; UROKINASE; VITRONECTIN;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FETUS; HUMAN; HUMAN CELL; INCUBATION TIME; PROTEIN DEGRADATION; THYROID CELL;

EID: 0032734881     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(99)80081-9     Document Type: Article

References (17)

1. Vassalli J.D. The urokinase receptor. Fibrinolysis. 8:1994;172-181.
2. Ploug M., Ronne E., Behrendt N., Jensen A.L., Blasi F., Dano K. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphadylinositol. J. Biol. Chem. 266:1991;1926-1933.
3. Blasi F., Conese M., Moller L.B., Pedersen N., Cavallaro U., Cubellis M.V., Fazioli F., Hernandez-Marrero L., Limongi P., Munoz-Canoves P., Resnati M., Riittinen L., Sidenius N., Soravia E., Soria M.R., Stoppelli M.P., Talarico D., Teesalu T., Valcamonica S. The urokinase receptor: structure, regulation and inhibitor-mediated internalization. Fibrinolysis. 8:1994;189-203.
4. Wei Y., Waltz D.A., Rao N., Drummond R.J., Rosenberg S., Chapman H.A. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:1994;32380-32388.
5. Wei Y., Lukashev M., Simon D.I., Bodary S.C., Rosenberg S., Doyle M.V., Chapman H.A. Regulation of integrin function by the urokinase receptor. Science. 273:1996;1551-1555.
6. 2-terminal domain of the urokinase receptor. FEBS Lett. 288:1991;233-236.
7. Resnati M., Guttinger M., Valcamonica S., Sidenius N., Blasi F., Fazioli F. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J. 15:1996;1572-1582.
8. Blasi F. uPAR-uPA-PAI-1: a key intersection in proteolysis, adhesion and chemotaxis. Immunol. Today. 18:1997;415-417.
9. Sitrin R.G., Todd R.F. III, Petty H.R., Brock T.G., Shollenberger S.B., Albrecht E., Gyetko M.R. The urokinase receptor (CD 87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J. Clin. Invest. 97:1996;1942-1951.
10. Busso N., Masur S.K., Lazega D., Waxman S., Ossowski L. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cell. J. Cell Biol. 126:1994;259-270.
11. Hoyer-Hansen G., Ronne E., Solberg H., Behrendt N., Ploug M., Lund L.R., Ellis V., Dano K. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J. Biol. Chem. 267:1992;18224-18229.
12. Fazioli F., Resnati M., Sidenius N., Higashimoto Y., Appella E., Blasi F. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J. 16:1997;7279-7286.
13. Ragno P., Montuori N., Covelli B., Hoyer-Hansen G., Rossi G. Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in normal and tumor thyroid cells. Cancer Res. 58:1998;1315-1319.
14. Cone R.D., Platzer M., Piccinini L.A., Jaramillo M., Davies T.F. HLA-DR gene expression in a proliferating human thyroid cell clone. Endocrinology. 123:1988;2067-2074.
15. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
16. Bianchi E., Ferrero E., Fazioli F., Mangili F., Wang J., Bender J.R., Blasi F., Pardi R. Integrin-dependent induction of functional urokinase receptors in primary-T lymphocytes. J. Clin. Invest. 98:1996;1133-1141.
17. Albelda S.M. Biology of disease. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest. 68:1993;4-17.